FDA clamps down on proliferation of 7-OH products
The U.S. Food and Drug Administration announced on Tuesday that it is recommending a scheduling action to control certain 7-hydroxymitragynine (7-OH) products under the Controlled Substances Act.
Archives for July 29, 2025
ClostraBio self-affirms GRAS status for next-gen probiotic CLB101
Chicago-based ClostraBio, Inc. has announced that an independent expert panel has confirmed the self-affirmed Generally Recognized as Safe (GRAS) status of its Anaerostipes caccae CLB101 probiotic strain. The designation clears the way for ClostraBio to...
Short-staffed FDA delays NMN citizen petition response
The U.S. Food and Drug Administration (FDA) has delayed its response to a citizen petition regarding nicotinamide mononucleotide (NMN), citing agency-wide staffing reductions and administrative setbacks.
BAPP Bulletin puts echinacea adulteration under the microscope
A new bulletin from the Botanical Adulterants Prevention Program (BAPP) details the latest adulteration and mislabeling detected in the echinacea supply chain. It reports the presence of undeclared Echinacea species and plant parts, as well as...
Synbiotic formula may support infant growth and protect against pathogens
An infant formula supplemented with six human milk oligosaccharides and two probiotics may support healthy, age-appropriate growth and improve gut health, according to new research.
Study highlights high incidence of ‘growing pains’ in young athletes
Idiopathic musculoskeletal pain may occur in up to nearly 94% of children and adolescents in sports academies and clubs, highlighting the need for early nutrition intervention.